SCHEMBL1963500

SCHEMBL1963500

CCOC(=O)c1cccc(Nc2ccccc2)c1C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.55
CDC25B P30305 6/20 0.54
CDC25A P30304 1/20 0.54
CDC25C P30307 1/20 0.54
TSHR P16473 3/20 0.54
MAPT P10636 1/20 0.54
ALOX15 P16050 1/20 0.54
KMT2A Q03164 1/20 0.51
ALDH1A1 P00352 2/20 0.50
TP53 P04637 1/20 0.50
HTT P42858 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
LMNA P02545 1/20 0.50
MAPK10 P53779 1/20 0.49
KDM4E B2RXH2 3/20 0.49
HSD17B10 Q99714 2/20 0.49
FABP4 P15090 1/20 0.49
SPR P35270 1/20 0.48
CYP1A2 P05177 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1964221 0.89 ALDH1A1 (0.53) CDC25BCDC25ACDC25CMAPTKMT2A
SCHEMBL1962425 0.87 MAPT (0.48) ATMCDC25BCDC25ACDC25CTSHR
SCHEMBL1962162 0.87 CDC25B (0.46) ATMCDC25BCDC25ACDC25CTSHR
SCHEMBL1964167 0.87 DHODH (0.48) ATMCDC25BCDC25ACDC25CTSHR
SCHEMBL2008034 0.87 MAPT (0.71) ATMCDC25BCDC25ACDC25CTSHR
SCHEMBL1961347 0.86 AKR1C3 (0.57) CDC25BCDC25ACDC25CTSHRMAPT
SCHEMBL1961864 0.86 CDC25B (0.53) ATMCDC25BCDC25ACDC25CTSHR
SCHEMBL1962918 0.84 CDC25B (0.59) CDC25BCDC25ACDC25CTSHRMAPT
SCHEMBL1961719 0.83 CTSV (0.55) CDC25BCDC25ACDC25CMAPTKMT2A
SCHEMBL1963158 0.83 TDP1 (0.44) ATMCDC25BCDC25ACDC25CTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919892-B1 ISOINDOLE-IMIDE COMPOUNDS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME CELGENE CORP (US) 2013-08-14 EP disclosed
US-8481568-B2 Isoindole-imide compounds and compositions comprising and methods of using the same CELGENE CORPORATION (US) 2013-07-09 US disclosed
US-20110144158-A1 ISOINDOLE-IMIDE COMPOUNDS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME SEPRACOR INC. 2011-06-16 US disclosed
EP-1919892-A2 ISOINDOLE-IMIDE COMPOUNDS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME CELGENE CORPORATION (US) 2008-05-14 EP disclosed
WO-2007027527-A2 ISOINDOLE-IMIDE COMPOUNDS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME CELGENE CORPORATION (US) 2007-03-08 WO disclosed
US-20070049618-A1 Isoindole-imide compounds and compositions comprising and methods of using the same CELGENE CORPORATION 2007-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110144158-A1 ISOINDOLE-IMIDE COMPOUNDS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME SI, CYP3A5, CYP2D6 ATM 3923/4885CDC25B 420/4885CDC25A 618/4885
US-20070049618-A1 Isoindole-imide compounds and compositions comprising and methods of using the same SI, CYP3A5, CYP2D6 ATM 3923/4885CDC25B 420/4885CDC25A 618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.